Sr Brand Manager, Alzheimer's Diagnostics UK

Overview

Unsere Arbeit bei Lilly ist anspruchsvoll, weil Patienten unsere Medikamente benötigen. Mit unserer Forschungsarbeit verfolgen wir das Ziel, das Leben von Menschen auf der ganzen Welt besser zu machen. Dabei ist uns bewusst, dass jede Entscheidung, jedes Detail und jeder Tag zählt. Unser Hauptsitz befindet sich in Indianapolis im US-Bundesstaat Indiana. Mit über 50.000 Mitarbeitern auf der ganzen Welt stellen wir uns komplexen Herausforderungen, um bahnbrechende Medikamente zu entwickeln und auf den Markt zu bringen, unsere Kenntnisse über Gesundheit und die Behandlung von Krankheiten zu verbessern und Patienten zu unterstützen. Dies ist eine intensive, vordringliche und aufopferungsvolle, aber dennoch erfüllende Tätigkeit. Wenn du motiviert und bereit bist, dein Bestes für eine Aufgabe zu geben, die für Patienten wirklich zählt, würden wir uns freuen, dich in unserem Team willkommen zu heißen.

Job title: Senior Brand Manager – Alzheimer’s Diagnostics

Location: Basingstoke

Hybrid/Remote: Hybrid – 3 days a week office based

Reports to: Neuro Brand Lead UK/ROI

About Lilly:

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

Role Overview:

The Alzheimer’s opportunity is one of the most exciting we have seen in the history of Lilly. Alzheimer’s disease (AD) is one of the leading causes of death in the UK, with no current medications for cure or prevention. Lilly has 30+ years of investment in AD research and development across both therapeutics and diagnostics. The UK ecosystem is not ready to implement disease-modifying medications at this time and has no defined diagnostic pathway for patients with early Alzheimer's Disease. The role of the Alzheimer's Diagnostics Brand Manager is to prepare the ecosystem to support accurate and timely diagnoses of Alzheimer’s Disease. They will help HCPs see the value of biomarker diagnostic tools to confirm AD diagnosis and unlock the ability to diagnose patients earlier and more accurately. The Alzheimer's Diagnostics Brand Manager will implement strategies to increase the use of cognitive assessments, blood biomarkers, CSF biomarkers, and PET tracers.

The successful Marketing candidate will need to work closely and in strong collaboration with key cross functional stakeholders across Global, IBU and local colleagues to deliver on the key diagnostic priorities. This individual will need to work with several other enabling functions including PRA, Medical, OCE, Regulatory, Finance, E&C, sales, Corporate Affairs, IBU, Global.

Key Responsibilities

• Be the commercial subject matter expert of the diagnostic landscape for Alzheimer’s in the UK and Ireland, competitor efforts and the needs of patients, caregivers, physicians and payers
• Develop and implement initiatives to increase the use of cognitive assessments, blood biomarkers, CSF biomarkers, and PET tracers, in both the private and public market, working in close partnership with PRA, B2B, and field teams
• Partner with B2B and field teams to unlock diagnostic readiness and volume at the HCO/site level
• Develop compliant private and public market diagnostic package solutions with healthcare organizations (HCOs) and implement in partnership with field teams
• Develop localised diagnostic education marketing materials for brand and field execution from the Global diagnostic strategy that drive belief and behaviour change across customer specialties (GP, OAP, Neurologists)
• Own and execute diagnostic manufacturer partnerships as the primary commercial point of contact, partnering closely with PRA, B2B, and field teams on strategy and pull-through of all collaborative diagnostic plans — including efforts to boost blood-based biomarker (BBM) and diagnostic awareness and adoption
• Partner with PRA team to align and execute on the Dx access strategy
• Provide commercial point of view when and where appropriate on diagnostic development and label discussions
• Lead digital cognitive assessment and blood based biomarker market research and develop the associated action plan following read-out
• Develop, aggregate, and report on all diagnostics activities and usage data; facilitate data integration from lab and private site data purchase agreements and BI&A
• Responsible for understanding, implementation, and adherence to company policies, processes, and external obligations, as applicable
• Operate in compliance with the Red Book, Customer Information Quality (CIQ) procedures and t

Commercial Diagnostic strategy :

Operations & Execution Excellence: